PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1543674
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1543674
Global Recombinant Chemicals Market Size Study, by Product Type, by Technology, by Application, and Regional Forecasts 2022-2032
The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032. Recombinant chemicals, produced through genetic engineering techniques, include recombinant proteins, DNAs, and peptides. Recombinant proteins are polypeptides produced from cloned genes and are widely employed in fields such as medicine, research, and biotechnology due to their advantages such as high purity, specificity, efficiency, safety, customization, scalability, and consistency. Recombinant proteins are used in vaccine development, therapeutics, diagnostics, and drug discovery and development. They include cytokines, enzymes, hormones, blood clotting factors, growth factors, monoclonal antibodies (mAbs), and antibody-related products. Recombinant protein vaccines are considered safer than vaccines derived from live viruses as they are non-replicating and lack infectious components.
The rise in demand for recombinant protein vaccines is significantly driving the market value of recombinant chemicals. Recombinant protein vaccines, which constitute a proven and well-established vaccine development platform, are particularly in demand due to the increased need for recombinant protein-based SARS-CoV-2 vaccines, thereby augmenting the demand for DNA-derived chemicals. The prevalence of genetic disorders is also fueling the recombinant chemicals market development. Medicinal products produced through recombinant DNA technology have revolutionized the treatment and management of various genetic disorders. Key players operating in the recombinant chemicals market are producing high-purity recombinant products for studying antibody and enzyme binding sites, as well as novel small therapeutics, drug agents, and vaccines.
Recombinant DNA technology, which involves the joining of DNA molecules from two different species, is gaining traction in the production of pharmaceutical and biotechnological products, including nutraceuticals. Products such as Elelyso, which contains the active substance taliglucerase alfa, are produced using recombinant DNA technology for the treatment of genetic disorders like type 1 Gaucher disease.
Key regions considered for the global Recombinant Chemicals Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. In 2023, North America stands out as the dominating region. This dominance is primarily driven by the presence of advanced biotechnology infrastructure, significant investments in research and development, and the presence of major pharmaceutical and biotech companies. Additionally, strong support from government initiatives and a high demand for biopharmaceuticals contribute to North America's leading position in this market. On the other hand, the Asia-Pacific region is the fastest-growing market for recombinant chemicals. The rapid growth in this region is fueled by increasing healthcare expenditures, a growing biotech industry, and rising investments in life sciences research. Countries like China and India are at the forefront of this growth due to their expanding pharmaceutical sectors, favorable government policies, and a rising focus on precision medicine. Additionally, the availability of a skilled workforce and the establishment of new biotech startups further accelerate the market expansion in the Asia-Pacific region.
Major market players included in this report are:
- Genentech, Inc.
- Amgen Inc.
- Biogen
- Pfizer, Inc.
- Novartis AG
- Merck & Co.
- Sanofi
- F. Hoffmann-La Roche AG
- Johnson & Johnson Services, Inc.
- Bayer AG
- Mitsubishi Chemical Group
- Bharat Serums and Vaccines (BSV)
- Serum Institute of India
- University of Sao Paulo (USP)
- Oswaldo Cruz Foundation (FIOCRUZ)
The detailed segments and sub-segment of the market are explained below:
By Product Type:
- Recombinant Proteins
- Recombinant DNAs
- Recombinant Peptides
- Others
By Technology:
- Microbial Expression Systems
- Mammalian Cell Expression Systems
- Yeast Expression Systems
- Insect Cell Expression Systems
- Cell-free Expression Systems
By Application:
- Drug Development
- Vaccine Production
- Therapeutics
- Cell Line Development
- Agriculture
- Food and Beverage
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- RoMEA
Years considered for the study are as follows:
- Historical year - 2022
- Base year - 2023
- Forecast period - 2024 to 2034
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
Table of Contents
Chapter 1. Global Recombinant Chemicals Market Executive Summary
- 1.1. Global Recombinant Chemicals Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Product Type
- 1.3.2. By Technology
- 1.3.3. By Application
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Recombinant Chemicals Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
Chapter 3. Global Recombinant Chemicals Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Rise in Demand for Recombinant Protein Vaccines
- 3.1.2. Surge in Prevalence of Genetic Disorders
- 3.2. Market Challenges
- 3.2.1. Economic Uncertainty and Cost Concerns
- 3.3. Market Opportunities
- 3.3.1. Innovations in Recombinant DNA Technology
- 3.3.2. Expansion of Application Areas
Chapter 4. Global Recombinant Chemicals Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top investment opportunity
- 4.4. Top winning strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Recombinant Chemicals Market Size & Forecasts by Product Type 2022-2032
- 5.1. Segment Dashboard
- 5.2. Global Recombinant Chemicals Market: Product Type Revenue Trend Analysis, 2022 & 2032(USD Billion)
- 5.2.1. Recombinant Proteins
- 5.2.2. Recombinant DNAs
- 5.2.3. Recombinant Peptides
- 5.2.4. Others
Chapter 6. Global Recombinant Chemicals Market Size & Forecasts by Technology 2022-2032
- 6.1. Segment Dashboard
- 6.2. Global Recombinant Chemicals Market: Technology Revenue Trend Analysis, 2022 & 2032(USD Billion)
- 6.2.1. Microbial Expression Systems
- 6.2.2. Mammalian Cell Expression Systems
- 6.2.3. Yeast Expression Systems
- 6.2.4. Insect Cell Expression Systems
- 6.2.5. Cell-free Expression Systems
Chapter 7. Global Recombinant Chemicals Market Size & Forecasts by Application 2022-2032
- 7.1. Segment Dashboard
- 7.2. Global Recombinant Chemicals Market: Application Revenue Trend Analysis, 2022 & 2032(USD Billion)
- 7.2.1. Drug Development
- 7.2.2. Vaccine Production
- 7.2.3. Therapeutics
- 7.2.4. Cell Line Development
- 7.2.5. Agriculture
- 7.2.6. Food and Beverage
- 7.2.7. Others
Chapter 8. Global Recombinant Chemicals Market Size & Forecasts by Region 2022-2032
- 8.1. North America Recombinant Chemicals Market
- 8.1.1. U.S. Recombinant Chemicals Market
- 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
- 8.1.1.2. Technology breakdown size & forecasts, 2022-2032
- 8.1.1.3. Application breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Recombinant Chemicals Market
- 8.1.1. U.S. Recombinant Chemicals Market
- 8.2. Europe Recombinant Chemicals Market
- 8.2.1. UK Recombinant Chemicals Market
- 8.2.2. Germany Recombinant Chemicals Market
- 8.2.3. France Recombinant Chemicals Market
- 8.2.4. Spain Recombinant Chemicals Market
- 8.2.5. Italy Recombinant Chemicals Market
- 8.2.6. Rest of Europe Recombinant Chemicals Market
- 8.3. Asia-Pacific Recombinant Chemicals Market
- 8.3.1. China Recombinant Chemicals Market
- 8.3.2. India Recombinant Chemicals Market
- 8.3.3. Japan Recombinant Chemicals Market
- 8.3.4. Australia Recombinant Chemicals Market
- 8.3.5. South Korea Recombinant Chemicals Market
- 8.3.6. Rest of Asia Pacific Recombinant Chemicals Market
- 8.4. Latin America Recombinant Chemicals Market
- 8.4.1. Brazil Recombinant Chemicals Market
- 8.4.2. Mexico Recombinant Chemicals Market
- 8.4.3. Rest of Latin America Recombinant Chemicals Market
- 8.5. Middle East & Africa Recombinant Chemicals Market
- 8.5.1. Saudi Arabia Recombinant Chemicals Market
- 8.5.2. South Africa Recombinant Chemicals Market
- 8.5.3. Rest of Middle East & Africa Recombinant Chemicals Market
Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Genentech, Inc.
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Market Strategies
- 9.3.2. Amgen Inc.
- 9.3.3. Biogen
- 9.3.4. Pfizer, Inc.
- 9.3.5. Novartis AG
- 9.3.6. Merck & Co.
- 9.3.7. Sanofi
- 9.3.8. F. Hoffmann-La Roche AG
- 9.3.9. Johnson & Johnson Services, Inc.
- 9.3.10. Bayer AG
- 9.3.11. Mitsubishi Chemical Group
- 9.3.12. Bharat Serums and Vaccines (BSV)
- 9.3.12. Serum Institute of India
- 9.3.14. University of Sao Paulo (USP)
- 9.3.15. Oswaldo Cruz Foundation (FIOCRUZ)
- 9.3.1. Genentech, Inc.
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
